Wikipedia
Evolocumab
Evolocumab (trade name Repatha) is a monoclonal antibody designed for the treatment of hyperlipidemia.
Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9). PCSK9 is a protein that targets LDL receptors for degradation and thereby reduces the liver's ability to remove LDL-C, or "bad" cholesterol, from the blood.
In 2015 it cost about $14,300 USD per year which makes it not cost effective. It is made by Amgen.